TPM3, CHMP4C, EEF1A1, FASN, TNF, S100A10, and IL1A represent a high-risk score and poor prognosis, suggesting that these genes may be associated with the tumor process in patients with CC and appear to be pro-oncogenes. This evidence concerns the gene EEF1A1 and neoplasm.